← Back to Search

End-of-Life Conversation Game for Cancer

N/A

Recruiting

Led By Lauren Van Scoy, MD

Research Sponsored by Milton S. Hershey Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patient with Cancer: Be an individual diagnosed with a solid tumor cancer (e.g., breast, colon, lung, melanoma, head and neck, or genitourinary/prostate cancer) as verified by primary oncologist or is the chosen caregiver for a participant with those cancers

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to up to two years after participation in research event

Summary

This trial aims to see if a game called "Hello" can help individuals with different types of cancer and their loved ones talk about end-of-life care planning. Participants will play the game and then answer

Who is the study for?

This trial is for individuals with various solid cancers such as breast, lung, and colorectal cancer. Participants will be from Penn State Health clinics who are interested in advance care planning. They should be willing to answer questionnaires, play a game designed to facilitate end-of-life conversations, join a focus group discussion, and do a follow-up interview.

What is being tested?

The study tests the 'Hello for Cancer' game against the 'Table Topics' game to see if they help in advance care planning. It checks how these games affect healthcare usage like hospital stays or emergency visits and explores necessary changes for using Hello in cancer populations.

What are the potential side effects?

Since this trial involves playing conversation games rather than medical treatments, traditional side effects associated with medications are not expected. However, participants may experience emotional discomfort discussing end-of-life topics.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with a solid tumor cancer or am caring for someone who has.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to up to two years after participation in research event

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to up to two years after participation in research event

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to up to two years after participation in research event for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Healthcare Utilization

Perceptions of modified intervention

Secondary study objectives

Acceptability of Intervention Measure

Advance Care Planning Engagement Measure

Advance Care Planning Surrogate Decision Maker Engagement Measure

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Hello for Cancer gameExperimental Treatment1 Intervention

For this arm, individuals will play the modified Hello game (Hello for Cancer). This game was modified to be better suited for individuals with cancer and their loved ones, and those modifications are now being tested. This game will include questions related to a variety of topics around an individual's cancer experience and medical decision making related to their cancer diagnosis. After playing the game, individuals will be asked to reflect on the game questions and provide feedback to inform further modifications.

Group II: Table Topics gamePlacebo Group1 Intervention

For this arm, individuals will play commercially available Table Topics game during the research event. This game asks a variety of conversation starting questions, not particularly related to medical decision making.

0 / 1Eligibility criteria met